DrugDashboards

Uptravi

Selexipag · SELEXIPAG 150 ug/1 · Tablet, Film Coated · Oral · Actelion Pharmaceuticals US, Inc.

NDC 66215-0915-14 · 1 BOTTLE in 1 CARTON / 140 TABLET, FILM COATED in 1 BOTTLE · NDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $23,071.72 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA207947
TE code
AB
Approval date
Dec 21, 2015
Patents / exclusivity
120 patents, 20 exclusivities
TypeNumber / codeExpires
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityPEDNov 23, 2029
exclusivityNPPMay 23, 2029
exclusivityNPPMay 23, 2029

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Selexipag (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Actelion Pharmaceuticals US, Inc.SELEXIPAG 150 ug/1Jul 15, 2026Sep 2, 2026
Actelion Pharmaceuticals US, Inc.SELEXIPAG 100 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedSELEXIPAG 400 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedSELEXIPAG 1200 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedSELEXIPAG 600 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedSELEXIPAG 800 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedSELEXIPAG 1600 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedSELEXIPAG 200 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedSELEXIPAG 1000 ug/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedSELEXIPAG 1400 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.SELEXIPAG 800 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.SELEXIPAG 1000 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.SELEXIPAG 1200 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.SELEXIPAG 1400 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.SELEXIPAG 1600 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.SELEXIPAG 200 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.SELEXIPAG 400 ug/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals (USA) Inc.SELEXIPAG 600 ug/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Uptravi — NDC 66215-0915-14," retrieved September 3, 2026, https://drugdashboards.com/drug/66215091514.

Free to cite with attribution — see how the data is put together.